Clarifying Frizzled 2 function in development through genetically validated mouse models
Disease Models & Mechanisms · 2026
DOI: 10.1242/dmm.052410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Megan N Michalski und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Van Andel Institute, Grand Rapids, Michigan 49503, USA. Hauptthemen laut MEDLINE: Frizzled Receptors, Embryonic Development. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, Van Andel Research Institute, National Institute of Health.
Abstract (Originalsprache)
Wnt receptors of the Frizzled (Fzd) family are widely considered to exhibit substantial functional redundancy, complicating efforts to therapeutically target individual receptors. Fzd2 was believed to be functionally redundant with Fzd1 and Fzd7, based on previously published global knockout mouse studies. By contrast, homozygosity for a Fzd2 global knockout mouse allele developed by the International Mouse Phenotype Consortium (IMPC) has been reported to cause embryonic lethality, suggesting that Fzd2 is critical for early embryonic development. If global deletion of Fzd2 leads to early lethality, conditional deletion models are necessary to identify tissue-specific phenotypes. We found that a previously published Fzd2 conditional deletion model does not eliminate Fzd2. We have generated a new conditional model to address the contradictory previous studies and allow tissue-specific studies of Fzd2. We successfully inserted two loxP sites around the Fzd2 gene and confirmed that subsequent Cre-mediated recombination creates a Fzd2 null allele. Global deletion of Fzd2 in this model does not cause embryonic lethality while limb-specific deletion causes limb shortening. This work supports the hypothesis that Fzd2 regulates limb development and emphasizes the importance of thoroughly validating newly generated mouse models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Van Andel Institute, Grand Rapids, Michigan 49503, USA.
- Department of Structural Biology, Van Andel Institute, Grand Rapids, Michigan 49503, USA.
- Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada.
- School of Pharmacy, University of Waterloo, Kitchener, Ontario N2G 1C5, Canada.
- Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
- Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada.
ORCID-Profile: Bart O Williams
Förderung
- NIDCR NIH HHS
- Van Andel Research Institute
- National Institute of Health
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Michalski, M. N., Diegel, C. R., Zhong, Z. A., Marshall, M. E., Foxa Wiartalla, G. E., Stevens, P. D., Suino-Powell, K., Blazer, L. L., Adams, J. J., Melcher, K., Sidhu, S. S., Angers, S., & Williams, B. O. (2026). Clarifying Frizzled 2 function in development through genetically validated mouse models. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052410
Vancouver
Michalski MN, Diegel CR, Zhong ZA, Marshall ME, Foxa Wiartalla GE, Stevens PD, et al. Clarifying Frizzled 2 function in development through genetically validated mouse models. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052410
BibTeX
@article{Michalski2026,
author = {Michalski, Megan N and Diegel, Cassandra R and Zhong, Zhendong A and Marshall, Maddison E and Foxa Wiartalla, Gabrielle E and Stevens, Payton D and Suino-Powell, Kelly and Blazer, Levi L and Adams, Jarrett J and Melcher, Karsten and Sidhu, Sachdev S and Angers, Stephane and Williams, Bart O},
title = {Clarifying Frizzled 2 function in development through genetically validated mouse models},
journal = {Disease Models & Mechanisms},
year = {2026},
doi = {10.1242/dmm.052410}
}
EUVIMED